Scholarly open access journals, Peer-reviewed, and Refereed Journals, Impact factor 8.14 (Calculate by google scholar and Semantic Scholar | AI-Powered Research Tool) , Multidisciplinary, Monthly, Indexing in all major database & Metadata, Citation Generator, Digital Object Identifier(DOI)
Three-dimensional printing is transforming how medicines are made, shifting the pharmaceutical industry from large-scale, standardized production to a flexible, digitally driven model centered on individual patient needs. Instead of producing fixed-dose tablets for the general population, additive manufacturing allows for creating personalized medications tailored to each patient’s specific requirements. This approach enables precise dose control, customized release profiles, unique tablet shapes, and even the integration of multiple drugs into one dosage form improvements that greatly benefit children, elderly patients, and those managing complex treatment plans. Beyond personalizing medicine, 3D printing unlocks vast design possibilities. It can produce intricate internal structures that influence how drugs dissolve and are absorbed, incorporate new types of excipients, and accelerate drug development by making it easier to test prototypes quickly. Various additive manufacturing methods such as Fused Deposition Modelling, Stereolithography, and Selective Laser Sintering are being refined for pharmaceutical use, each offering distinct advantages in accuracy, production speed, and material compatibility. Another groundbreaking direction is decentralized drug manufacturing. By installing small-scale 3D printing systems in hospitals, clinics, and remote locations, it becomes possible to produce medicines on demand right where they’re needed. This distributed model could revolutionize emergency care, rare disease treatment, and healthcare delivery in resource-limited settings. Although challenges in quality control, regulation, and technology still exist, steady progress is being made. Advances in printable materials, digital design tools, and biocompatible substrates are rapidly bridging the gap between experimental research and real-world medical use. The combination of medical science, digital fabrication, and advanced materials is redefining how we design, produce, and deliver medicines marking a pivotal step toward the era of truly personalized health care.
Keywords:
3D Printing, Additive manufacturing, Personalized medicine, Inkjet printing, Poly-pills.
Cite Article:
"3d printing in pharmaceutical formulations ", International Journal for Research Trends and Innovation (www.ijrti.org), ISSN:2455-2631, Vol.10, Issue 12, page no.a212-a223, December-2025, Available :http://www.ijrti.org/papers/IJRTI2512028.pdf
Downloads:
000173
ISSN:
2456-3315 | IMPACT FACTOR: 8.14 Calculated By Google Scholar| ESTD YEAR: 2016
An International Scholarly Open Access Journal, Peer-Reviewed, Refereed Journal Impact Factor 8.14 Calculate by Google Scholar and Semantic Scholar | AI-Powered Research Tool, Multidisciplinary, Monthly, Multilanguage Journal Indexing in All Major Database & Metadata, Citation Generator